Stay updated with breaking news from Skye Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Skye Bioscience Inc (OTCQB:SKYE) said it has received a positive recommendation following a pre-specified data review by the safety review committee (SRC)...
Skye Bioscience Chairman & CEO Punit Dhillon joins Natalie Stoberman from the Proactive newsroom to share the announcement of its SBI-100 OE glaucoma...
Skye Bioscience CEO Punit Dhillon joins Natalie Stoberman in the Proactive studio to share November's milestones. Dhillon says the company has submitted an...
San Diego, California--(Newsfile Corp. - November 22, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative
Skye will continue to pursue Canadian Securities Exchange listing following closing of transaction Vancouver, British Columbia--(Newsfile Corp. - November 7, 2022) - Emerald Health Therapeutics, Inc.